CME Group (CME) to Release Quarterly Earnings on Wednesday

CME Group (NASDAQ:CMEGet Free Report) is projected to issue its quarterly earnings data before the market opens on Wednesday, February 12th. Analysts expect the company to announce earnings of $2.46 per share and revenue of $1.51 billion for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

CME Group Stock Performance

Shares of CME opened at $242.53 on Wednesday. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a 50-day moving average of $234.95 and a 200-day moving average of $223.06. The company has a market cap of $87.40 billion, a PE ratio of 25.50, a P/E/G ratio of 5.37 and a beta of 0.57. CME Group has a one year low of $190.70 and a one year high of $249.02.

CME Group Increases Dividend

The business also recently declared a dividend, which was paid on Thursday, January 16th. Shareholders of record on Friday, December 27th were paid a dividend of $5.80 per share. The ex-dividend date was Friday, December 27th. This is an increase from CME Group’s previous dividend of $2.50. CME Group’s payout ratio is 48.37%.

CME Group declared that its board has initiated a share repurchase plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its shares are undervalued.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CME shares. Oppenheimer lifted their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research note on Monday, January 6th. Piper Sandler lifted their price target on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and cut their target price for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. Finally, Keefe, Bruyette & Woods cut their target price on CME Group from $260.00 to $256.00 and set a “market perform” rating on the stock in a research note on Monday, January 13th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $229.27.

View Our Latest Stock Analysis on CME

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Earnings History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.